Paris, April 22, 2021 – Mastering uncertainty has never been so important for healthcare manufacturers. Whether for clinical development, market access, or commercial efficiency, the ability to integrate and exploit the various sources of available data, and in particular real-world data, is now a critical success factor.
By combining the unique experience of the seven partners of Euresis Partners, former senior executives of the pharmaceutical industry, with the know-how and technologies of Quinten Health, a pioneer in the field of artificial intelligence applied to healthcare, the two partners intend to offer a unique range of integrated services, from the identification of opportunities to the deployment of customized decision support solutions for a better understanding of diseases, effectiveness and safety of treatments, and prescribing behaviors.
“Quinten Health’s proven experience in artificial intelligence and data science, combined with our indepth understanding of the challenges and processes of the healthcare industry, allows us to offer our clients a unique range of services across their entire value chain,” said Robert Dahan, President of Euresis Partners.
“This partnership will allow us to integrate AI and digital technologies into the core strategies and vision of healthcare decision makers in a sustainable and efficient manner” added Billy Amzal, CEO of Quinten Health
